Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

JJasper Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
J

Jasper Therapeutics, Inc.

$0.62Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $3.58M. Net result −$2.76M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $3.58M. Running result $3.58M. Revenue: $3.58M.
  • Cost of revenue: −$3.58M. Running result $0.
  • Gross profit: $0. Running result $0.
  • Research and development: −$5.14M. Running result −$5.14M.
  • General and administrative: −$4.07M. Running result −$9.21M.
  • Operating income: −$9.21M. Running result −$9.21M.
  • Other income: $6.45M. Running result −$2.76M.
  • Pre-tax loss: −$2.76M. Running result −$2.76M.
  • Income tax benefit: $0. Running result −$2.76M.
  • Net loss: −$2.76M. Running result −$2.76M.